Gilead Sciences
GILD
#129
Rank
โ‚น13.512 T
Marketcap
โ‚น10,890
Share price
-1.14%
Change (1 day)
40.82%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น3.330 Trillion

According to Gilead Sciences's latest financial reports the company's total liabilities are โ‚น3.330 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น3.409 T4.02%
2023-12-31โ‚น3.278 T-5.6%
2022-12-31โ‚น3.472 T-0.5%
2021-12-31โ‚น3.489 T-4.91%
2020-12-31โ‚น3.670 T32.05%
2019-12-31โ‚น2.779 T-5.67%
2018-12-31โ‚น2.946 T-7.3%
2017-12-31โ‚น3.178 T24.36%
2016-12-31โ‚น2.556 T17.97%
2015-12-31โ‚น2.166 T81.41%
2014-12-31โ‚น1.194 T78.44%
2013-12-31โ‚น669.32 B4.52%
2012-12-31โ‚น640.39 B16%
2011-12-31โ‚น552.05 B125.19%
2010-12-31โ‚น245.14 B65.45%
2009-12-31โ‚น148.17 B24.75%
2008-12-31โ‚น118.78 B35.45%
2007-12-31โ‚น87.69 B-10.7%
2006-12-31โ‚น98.19 B195.47%
2005-12-31โ‚น33.23 B169.17%
2004-12-31โ‚น12.34 B-50.85%
2003-12-31โ‚น25.12 B-26.92%
2002-12-31โ‚น34.37 B108.1%
2001-12-31โ‚น16.51 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚น7.233 T 117.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น677.68 B-79.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น12.262 T 268.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น341.01 B-89.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น988.20 B-70.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น10.388 T 211.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.199 T 206.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น8.182 T 145.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.974 T 109.40%๐Ÿ‡บ๐Ÿ‡ธ USA